A study looking at online reporting of side effects at home after cancer treatment (ePRIME)

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Other

Details

ePRIME is a web based system for patients to report symptoms while they are at home, alongside a blood test and telephone review. The researchers wanted to find out how well it would work for women on follow up after treatment for:

The aims were to find out:

how well the ePRIME system works
about the patients’ experiences

The study was open for people to join between 2017 and 2020. The team published the results in 2022 and 2023.

Recruitment start: 16 January 2017

Recruitment end: 31 January 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Galina Velikova

Supported by

Yorkshire Cancer Research (funder)

Leeds Teaching Hospitals NHS Trust

University of Leeds

Calderdale & Huddersfield NHS Foundation Trust

NIHR Clinical Research Network

Other information

This study was funded by a grant from Yorkshire Cancer Research, grant reference L392, “ePRIME Yorkshire - electronic Patient self-Reported outcomes to Improve cancer Management and patient Experiences”. The charity had no influence on the data collection, interpretation or reporting.

Last reviewed: 05 Mar 2024

CRUK internal database number: 14613